The present review focuses on the use of Metal–Organic Frameworks, (MOFs) highlighting the most recent developments in the biological field and as bio-sensors.

Organic photovoltaic (OPV) devices, made with semiconducting polymers, have recently attained a power conversion efficiency (PCE) over 14% in single junction cells and over 17% in tandem cells. These high performances, together with the suitability of the technology to inexpensive large-scale manufacture, over lightweight and flexible plastic substrates using roll-to-roll (R2R) processing, place the technology amongst the most promising for future harvesting of solar energy. Although OPVs using non-fullerene acceptors have recently outperformed their fullerene-based counterparts, the research in the development of new fullerenes and in the improvement of the bulk-heterojunction (BHJ) morphology and device efficiency of polymer:fullerene solar cells remains very active. In this review article, the most relevant research works performed over the last 3 years, that is, since the year 2016 onwards, in the field of fullerene-based polymer solar cells based on the copolymers PTB7, PTB7-Th (also known as PBDTTT-EFT) and PffBT4T-2OD, are presented and discussed. This review is primarily focused on studies that involve the improvement of the BHJ morphology, efficiency and stability of small active area devices (typically < 15 mm²), through the use of different processing strategies such as the use of different fullerene acceptors, different processing solvents and additives and different thermal treatments.

The post-functionalization of 5,10,15-tris(1-methylpyridinium-4-yl)-20-(pentafluorophenyl)porphyrin tri-iodide, known as a highly efficient photosensitizer (PS) for antimicrobial photodynamic therapy (aPDT), in the presence of 3- or 4-mercaptobenzoic acid, afforded two new tricationic porphyrins with adequate carboxylic pending groups to be immobilized on chitosan or titanium oxide. The structural characterization of the newly obtained materials confirmed the success of the porphyrin immobilization on the solid supports. The photophysical properties and the antimicrobial photodynamic efficacy of the non-immobilized porphyrins and of the new conjugates were evaluated. The results showed that the position of the carboxyl group in the mercapto units or the absence of these substituents in the porphyrin core could modulate the action of the photosensitizer towards the bioluminescent Gram-negative Escherichia coli bacterium. The antimicrobial activity was also influenced by the interaction between the photosensitizer and the type of support (chitosan or titanium dioxide). The new cationic porphyrins and some of the materials were shown to be very stable in PBS and effective in the photoinactivation of E. coli bacterium. The physicochemical properties of TiO₂ allowed the interaction of the PS with its surface, increasing the absorption profile of TiO₂, which enables the use of visible light, inactivating the bacteria more efficiently than the corresponding PS immobilized on chitosan.

In medical applications such as drug delivery, gene transfection and imaging the formation of systems with well-defined sizes and shapes are of significant interest. For this reason the design of dendrimers with modulated size, shape, branching length/density, and their surface functionality, clearly distinguishes these structures as unique and optimum carriers for medical applications. The bioactive agents may be encapsulated into the interior of the dendrimers or chemically attached/physically adsorbed onto the dendrimer surface, with the option of tailoring the carrier to the specific needs of the active material and its therapeutic applications. In this regard one area with growing attention is photodynamic therapy (PDT) where a photosensitizer combined with light and molecular oxygen can easily cause irreversible damage to the target tissue. Nevertheless most of the photosensitizers have solubility issues when attempts are made to dissolve them in aqueous environments, hampering in most cases their medical applicability. Currently, investigations are running towards the combination of these photosensitizers with dendrimers increasing their organization, solubility and specificity to the target tissues. In this communication we review the latest advancements in the synthesis of porphyrin and phthalocyanine dendrimer architectures, regarding their utility as biomedical agents.